ELOCTATE

Swiss trademark · 631752 · Word mark · In force

Register entry

Registration number
631752
Application number
50786/2012
Status
In force
Type
Word mark
Filed
Jan 24, 2012
Registered
Jul 12, 2012
Published
Jul 12, 2012
Protected until
Jan 24, 2032
Priority
31.08.2011 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von Hämophilie.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  2. Nov 18, 2021

    Renewed

    Published in Swissreg on 18.11.2021

  3. Oct 6, 2016

    Transferred

    Owner
    Biogen MA Inc., 250 Binney Street, Cambridge, MA 02142, USA → Swedish Orphan Biovitrum AB (Publ), 112 76 Stockholm, Sweden

    Published in Swissreg on 06.10.2016

  4. May 24, 2016

    Holder’s address changed

    Owner
    Biogen Idec MA Inc., a corporation, organized under the laws of Massachusetts, USA, 14 Cambridge Center, Cambridge, MA 02142, USA → Biogen MA Inc., 250 Binney Street, Cambridge, MA 02142, USA

    Published in Swissreg on 24.05.2016

  5. Jul 12, 2012

    Registered

    Published in Swissreg on 12.07.2012

Parties

Holder

Swedish Orphan Biovitrum AB (Publ)

112 76 Stockholm, SE

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.